NPPA suggests expanding the list of essential medicines whose prices are controlled

Domestic and foreign companies pour in a slew of investments in Gujarat.

Sun maintained it would retain the best of both organisations to build a global pharma...

A source said the competition watchdog would by next month suggest 'structural...

US country head, key departmental heads leave; more likely to follow.

Competition in the US pharmaceutical market swelled in recent years, with increasing...

No Ebola case detected in the country so far; experts say a robust preparedness plan to...

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Currently, the govt directly caps prices of 348 formulations at the average price of...

Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides...

It hopes to turn around Ranbaxy within four years of closing the deal by improving...

The idea is to keep a close watch on real-time price movements, the maximum retail...

The Ministry of Science and Technology has approached about a dozen well-known...

Ministerial consultations on, with recognition of the potential, and the need to not...

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit,...

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India,...

Sun-Ranbaxy are keen to complete the merger process.

In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an...

The Drug (Prices Control) Order implemented in May last year brought into its purview...

The company did not respond to specific queries on the project's expansion.